Trading halted — News pending (T1)
Halted Aug 21, 2026, 7:50 PM ET ET. No resumption time set. Price and volume are frozen at the last trade until the halt lifts.
InterCure Ltd.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $50.4M
- Price
- $0.8515
- % Change (Daily % change from the live per-ticker quote feed.)
- -2.01%
- Volume
- 2.9M
About
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.
Quick stats
Shares outstanding59.2M
Computed float6.5M
Float / shares11.0%
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001857030
Websitehttps://www.intercure.co
AI Summary
AI-generated1/6
standardbearishreverse split
InterCure Ltd. Announces 1-for-5 Reverse Share Split
InterCure announced a 1-for-5 reverse share split effective August 24, 2026, aimed at regaining compliance with Nasdaq’s $1.00 minimum bid price requirement.
The company expects to receive a Staff Delisting Determination but intends to appeal, allowing shares to continue trading during the process.
The reverse split will reduce authorized shares to 20 million and outstanding shares to approximately 11.8 million, with fractional shares rounded down.
Red flags
- Reverse split signals listing compliance risk
- Company expects to receive a Staff Delisting Determination from Nasdaq